Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2017

Conditions
Critical Illness
Interventions
DEVICE

Freestyle Navigator

Continuous glucose monitoring with the Freestyle Navigator for 72 hours or until discharge from the ICU

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Diabetes Care

INDUSTRY

lead

Massachusetts General Hospital

OTHER